213 related articles for article (PubMed ID: 24069372)
1. Claudin-3 overexpression increases the malignant potential of colorectal cancer cells: roles of ERK1/2 and PI3K-Akt as modulators of EGFR signaling.
de Souza WF; Fortunato-Miranda N; Robbs BK; de Araujo WM; de-Freitas-Junior JC; Bastos LG; Viola JP; Morgado-Díaz JA
PLoS One; 2013; 8(9):e74994. PubMed ID: 24069372
[TBL] [Abstract][Full Text] [Related]
2. Claudin-3 expression increases the malignant potential of lung adenocarcinoma cells: role of epidermal growth factor receptor activation.
Zhang L; Wang Y; Zhang B; Zhang H; Zhou M; Wei M; Dong Q; Xu Y; Wang Z; Gao L; Qu Y; Shi B; Zhu J; Yin Y; Chen Y; Sun L; Zhang W; Xu S; Ying G; Wang C
Oncotarget; 2017 Apr; 8(14):23033-23047. PubMed ID: 28160565
[TBL] [Abstract][Full Text] [Related]
3. EBP50 inhibits EGF-induced breast cancer cell proliferation by blocking EGFR phosphorylation.
Yao W; Feng D; Bian W; Yang L; Li Y; Yang Z; Xiong Y; Zheng J; Zhai R; He J
Amino Acids; 2012 Nov; 43(5):2027-35. PubMed ID: 22476347
[TBL] [Abstract][Full Text] [Related]
4. Translational up-regulation of Aurora-A in EGFR-overexpressed cancer.
Lai CH; Tseng JT; Lee YC; Chen YJ; Lee JC; Lin BW; Huang TC; Liu YW; Leu TH; Liu YW; Chen YP; Chang WC; Hung LY
J Cell Mol Med; 2010 Jun; 14(6B):1520-31. PubMed ID: 19799648
[TBL] [Abstract][Full Text] [Related]
5. Macrophages stimulate gastric and colorectal cancer invasion through EGFR Y(1086), c-Src, Erk1/2 and Akt phosphorylation and smallGTPase activity.
Cardoso AP; Pinto ML; Pinto AT; Oliveira MI; Pinto MT; Gonçalves R; Relvas JB; Figueiredo C; Seruca R; Mantovani A; Mareel M; Barbosa MA; Oliveira MJ
Oncogene; 2014 Apr; 33(16):2123-33. PubMed ID: 23644655
[TBL] [Abstract][Full Text] [Related]
6. Both mitogen-activated protein kinase (MAPK)/extracellular-signal-regulated kinases (ERK) 1/2 and phosphatidylinositide-3-OH kinase (PI3K)/Akt pathways regulate activation of E-twenty-six (ETS)-like transcription factor 1 (Elk-1) in U138 glioblastoma cells.
Mut M; Lule S; Demir O; Kurnaz IA; Vural I
Int J Biochem Cell Biol; 2012 Feb; 44(2):302-10. PubMed ID: 22085529
[TBL] [Abstract][Full Text] [Related]
7. Serotonin activates MAP kinase and PI3K/Akt signaling pathways in prostate cancer cell lines.
Dizeyi N; Hedlund P; Bjartell A; Tinzl M; Austild-Taskén K; Abrahamsson PA
Urol Oncol; 2011; 29(4):436-45. PubMed ID: 19926313
[TBL] [Abstract][Full Text] [Related]
8. Cell surface protein C23 affects EGF-EGFR induced activation of ERK and PI3K-AKT pathways.
Lv S; Dai C; Liu Y; Sun B; Shi R; Han M; Bian R; Wang R
J Mol Neurosci; 2015 Feb; 55(2):519-24. PubMed ID: 25015231
[TBL] [Abstract][Full Text] [Related]
9. Epidermal growth factor modulates claudins and tight junctional functions in ovarian cancer cell lines.
Ogawa M; Kojima T; Someya M; Nomura K; Takasawa A; Murata M; Tanaka S; Saito T; Sawada N
Histochem Cell Biol; 2012 Aug; 138(2):323-38. PubMed ID: 22544349
[TBL] [Abstract][Full Text] [Related]
10. PI3K/Akt and ERK1/2 signalling pathways are involved in endometrial cell migration induced by 17beta-estradiol and growth factors.
Gentilini D; Busacca M; Di Francesco S; Vignali M; Viganò P; Di Blasio AM
Mol Hum Reprod; 2007 May; 13(5):317-22. PubMed ID: 17350964
[TBL] [Abstract][Full Text] [Related]
11. Differential epidermal growth factor receptor signaling regulates anchorage-independent growth by modulation of the PI3K/AKT pathway.
Humtsoe JO; Kramer RH
Oncogene; 2010 Feb; 29(8):1214-26. PubMed ID: 19935697
[TBL] [Abstract][Full Text] [Related]
12. Blockade of epidermal growth factor- or heregulin-dependent ErbB2 activation with the anti-ErbB2 monoclonal antibody 2C4 has divergent downstream signaling and growth effects.
Jackson JG; St Clair P; Sliwkowski MX; Brattain MG
Cancer Res; 2004 Apr; 64(7):2601-9. PubMed ID: 15059917
[TBL] [Abstract][Full Text] [Related]
13. Claudin-18 coupled with EGFR/ERK signaling contributes to the malignant potentials of bile duct cancer.
Takasawa K; Takasawa A; Osanai M; Aoyama T; Ono Y; Kono T; Hirohashi Y; Murata M; Sawada N
Cancer Lett; 2017 Sep; 403():66-73. PubMed ID: 28624624
[TBL] [Abstract][Full Text] [Related]
14. The molecular chaperone Cosmc enhances malignant behaviors of colon cancer cells via activation of Akt and ERK.
Huang J; Che MI; Lin NY; Hung JS; Huang YT; Lin WC; Huang HC; Lee PH; Liang JT; Huang MC
Mol Carcinog; 2014 Feb; 53 Suppl 1():E62-71. PubMed ID: 23390052
[TBL] [Abstract][Full Text] [Related]
15. PtdIns(3,4,5)P3-dependent Rac Exchanger 1 (PREX1) Rac-Guanine Nucleotide Exchange Factor (GEF) Activity Promotes Breast Cancer Cell Proliferation and Tumor Growth via Activation of Extracellular Signal-regulated Kinase 1/2 (ERK1/2) Signaling.
Liu HJ; Ooms LM; Srijakotre N; Man J; Vieusseux J; Waters JE; Feng Y; Bailey CG; Rasko JE; Price JT; Mitchell CA
J Biol Chem; 2016 Aug; 291(33):17258-70. PubMed ID: 27358402
[TBL] [Abstract][Full Text] [Related]
16. Synergistic effect between EGF and TGF-beta1 in inducing oncogenic properties of intestinal epithelial cells.
Uttamsingh S; Bao X; Nguyen KT; Bhanot M; Gong J; Chan JL; Liu F; Chu TT; Wang LH
Oncogene; 2008 Apr; 27(18):2626-34. PubMed ID: 17982486
[TBL] [Abstract][Full Text] [Related]
17. miRs-134 and -370 function as tumor suppressors in colorectal cancer by independently suppressing EGFR and PI3K signalling.
El-Daly SM; Abba ML; Patil N; Allgayer H
Sci Rep; 2016 Apr; 6():24720. PubMed ID: 27095166
[TBL] [Abstract][Full Text] [Related]
18. EGF activates autocrine TGFα to induce prolonged egf receptor signaling and hepatocyte proliferation.
Liu S; Wierød L; Skarpen E; Grøsvik H; Duan G; Huitfeldt HS
Cell Physiol Biochem; 2013; 32(3):511-22. PubMed ID: 24008581
[TBL] [Abstract][Full Text] [Related]
19. Claudin-2 expression increases tumorigenicity of colon cancer cells: role of epidermal growth factor receptor activation.
Dhawan P; Ahmad R; Chaturvedi R; Smith JJ; Midha R; Mittal MK; Krishnan M; Chen X; Eschrich S; Yeatman TJ; Harris RC; Washington MK; Wilson KT; Beauchamp RD; Singh AB
Oncogene; 2011 Jul; 30(29):3234-47. PubMed ID: 21383692
[TBL] [Abstract][Full Text] [Related]
20. Requirement of the epidermal growth factor receptor in renal epithelial cell proliferation and migration.
Zhuang S; Dang Y; Schnellmann RG
Am J Physiol Renal Physiol; 2004 Sep; 287(3):F365-72. PubMed ID: 15213065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
